Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | RUNX1 | Q01196 | 2/20 | 0.42 |
| ▸ | CBFB | Q13951 | 2/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4753598 | 0.74 | CNR2 (0.37) | ALDH1A1GAAMAPTHPGDHTT | |
| SCHEMBL2660255 | 0.70 | ALDH1A1 (0.43) | ALDH1A1GAAMAPTHPGDHTT | |
| SCHEMBL28767925 | 0.68 | DYRK1A (0.42) | ALDH1A1GAAMAPTHPGDHTT | |
| SCHEMBL4965328 | 0.68 | — | — | |
| SCHEMBL6993258 | 0.67 | ALDH1A1 (0.47) | ALDH1A1GAAMAPTHPGDHTT | |
| SCHEMBL21241349 | 0.64 | ALDH1A1 (0.44) | ALDH1A1GAAMAPTHPGDHTT | |
| SCHEMBL2348958 | 0.63 | — | — | |
| SCHEMBL224905 | 0.62 | APP (0.48) | ALDH1A1GAAMAPTHPGDHTT | |
| SCHEMBL22014607 | 0.61 | ALDH1A1 (0.39) | ALDH1A1GAAMAPTHPGDHTT | |
| SCHEMBL22015413 | 0.59 | HPGDS (0.37) | ALDH1A1GAAMAPTHPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1954696-A2 | 2-PHENOXY-N-(1,3,4-THIADIZOL-2-YL)PYRIDIN-3-AMINE DERIVATIVES AND RELATED COMPOUNDS AS P2Y1 RECEPTOR INHIBITORS FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS | Bristol-Myers Squibb Company (US) | 2008-08-13 | — | — | EP | disclosed |
| WO-2006078621-A9 | 2-PHENOXY-N- (1, 3 , 4-THIADIZOL-2-YL) PYRIDIN-3-AMINE DERIVATIVES AND RELATED COMPOUNDS AS P2Y1 RECEPTOR INHIBITORS FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS | BRISTOL MYERS SQUIBB CO (US) | 2008-06-19 | — | — | WO | disclosed |
| WO-2006078621-A2 | 2-PHENOXY-N- (1, 3 , 4-THIADIZOL-2-YL) PYRIDIN-3-AMINE DERIVATIVES AND RELATED COMPOUNDS AS P2Y1 RECEPTOR INHIBITORS FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-07-27 | — | — | WO | disclosed |